Nelipepimut-S
Modify Date: 2025-08-29 17:51:01
Nelipepimut-S structure
|
Common Name | Nelipepimut-S | ||
|---|---|---|---|---|
| CAS Number | 160212-35-1 | Molecular Weight | 995.215 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 1354.5±65.0 °C at 760 mmHg | |
| Molecular Formula | C50H78N10O11 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 773.0±34.3 °C | |
Use of Nelipepimut-SNelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast cancer[1]. |
| Name | Nelipepimut-S |
|---|---|
| Synonym | More Synonyms |
| Description | Nelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
HER2 |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 1354.5±65.0 °C at 760 mmHg |
| Molecular Formula | C50H78N10O11 |
| Molecular Weight | 995.215 |
| Flash Point | 773.0±34.3 °C |
| Exact Mass | 994.585144 |
| LogP | 4.02 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.555 |
| NeuVax |
| L-Lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L-phenylalanyl-L-leucine |
| Nelipepimut-S |
| E75 peptide |
| 7M0A29CD8B |
| human receptor tyrosine-protein kinase erbB-2 (proto-oncogene Neu, tyrosine kinase- type cell surface receptor HER2, CD340)-(347-355)-peptide |
| L-Leucine, L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L-phenylalanyl- |